Table 1.

Baseline characteristics at the time of transplant admission

	Low-dose rATG induction ≤ 4.5 mg/kg (n = 83)	Standard-dose rATG induction > 4.5 mg/kg (n = 152)	P value
Age (mean), yr	13	12.1	0.2
Sex (male), %	62.7	61.2	0.83
Race, %			0.18
White	57	47
Black	26	38
Other	17	15
Etiology of ESKD, %			0.65
Obstructive uropathy/dysplasia	38	39.5
Focal segmental glomerulosclerosis	16	14.5
Other glomerular diseases	7	13
Unknown	4	4
Other	35	29
Transplant type (deceased), %	56.8	66.2	0.36
PRA (mean ± standard error), %
Class I	4.5 ± 1.6	2.3 ± 1	0.26
% Subjects with class I PRA > 80%	0	0
Class II	5.9 ± 1.7	2.1 ± 1.1	0.07
% Subjects with class II PRA > 80%	0	0
CMV risk, %			0.52
High	33	35
Intermediate	39	45
Low	28	20
EBV risk, %			0.29
High	19	31
Intermediate	78	65
Low	3	4

CMV, cytomegalovirus; EBV, Epstein-Barr virus; ESKD, end-stage kidney disease; PRA, panel reactive antibody; rATG, rabbit antithymocyte globulin.